DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Olopatadine Eye Drops and Allergy Skin Testing

Information source: Vanderbilt University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Allergic Rhinitis; Allergic Conjunctivitis

Intervention: olopatadine 0.2% opthalmic solution (Drug); placebo, normal saline opthalmic solution (Drug)

Phase: N/A

Status: Completed

Sponsored by: Vanderbilt University


Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.

Clinical Details

Official title: Effect of Olopatadine Hydrochloride 0.2% Ophthalmic Solution on Epicutaneous Skin Prick Testing With Histamine and Saline

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic

Primary outcome: The difference in area (mm2) of the wheal and flare histamine skin test response during treatment with olopatadine compared to placebo.


Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Both.


Inclusion Criteria:

- Adults aged 18 to 75 years

- Healthy volunteers (no major illnesses or active symptoms)

Exclusion Criteria:

- Known allergy or hypersensitivity to the drugs or components

- Pregnant or nursing women

- Women wishing to become pregnant during the study's duration

- Use of topical or oral medications with antihistaminic activity for 14 days

proceeding randomization

- Dermatographism as evidenced on skin testing on visit 1

- Chronic urticaria active within the past 6 months

- Severe hypertension

- Psychiatric diagnoses which could potentially affect medication compliance, such as

schizophrenia or delusional disorders, as determined by the investigator obtaining informed consent and based on the subject's past medical history

- Inability to provide informed consent

Locations and Contacts

Vanderbilt Asthma, Sinus and Allergy Program Research, Nashville, Tennessee 37203, United States
Additional Information

Starting date: January 2008
Last updated: October 17, 2008

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017